Recent Quotes

My Watchlist

Indicators

Currencies

International

Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

0.9018 +0.0018 (+0.20%)

Streaming Delayed Price Updated: 12:25 PM EST, Jan 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	13,082
Open	0.9000
Bid (Size)	0.9000 (100)
Ask (Size)	0.9036 (200)
Prev. Close	0.9000
Today's Range	0.8903 - 0.9077
52wk Range	0.7600 - 25.44
Shares Outstanding	6,297,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

January 14, 2026

Via ACCESS Newswire

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 12, 2026

Via ACCESS Newswire

Performance

YTD	+10.9%	+10.9%
1 Month	-6.1%	-6.1%
3 Month	-33.7%	-33.7%
6 Month	-69.6%	-69.6%
1 Year	-96.0%	-96.0%

More News

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

January 07, 2026

Via ACCESS Newswire

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

December 01, 2025

Via ACCESS Newswire

Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug ↗

September 09, 2025

Via Stocktwits

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 20, 2025

Via Benzinga

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

November 20, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 10, 2025

Via Benzinga

REVELATION BIOSCIENCES INC (NASDAQ:REVB) Reports Q3 2025 Loss, Announces Groundbreaking Clinical Data and Improved Cash Runway ↗

November 06, 2025

Via Chartmill

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

November 06, 2025

Via ACCESS Newswire

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

October 29, 2025

Via ACCESS Newswire

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

October 15, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 11, 2025

Via Benzinga

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

September 11, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

September 10, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 09, 2025

Via Benzinga

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

September 09, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 09, 2025

Via Benzinga

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

September 09, 2025

Via ACCESS Newswire

Revelation Biosciences Inc (NASDAQ:REVB) Reports Wider-Than-Expected Q2 2025 Loss, Extends Cash Runway to Year-End ↗

August 08, 2025

Via Chartmill

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

August 08, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

July 24, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

July 16, 2025

From Revelation Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 02, 2025

Via Benzinga

Frequently Asked Questions

Is Revelation Biosciences, Inc. - Common Stock publicly traded?

Yes, Revelation Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Revelation Biosciences, Inc. - Common Stock trade on?

Revelation Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Revelation Biosciences, Inc. - Common Stock?

The ticker symbol for Revelation Biosciences, Inc. - Common Stock is REVB on the Nasdaq Stock Market

What is the current price of Revelation Biosciences, Inc. - Common Stock?

The current price of Revelation Biosciences, Inc. - Common Stock is 0.9018

When was Revelation Biosciences, Inc. - Common Stock last traded?

The last trade of Revelation Biosciences, Inc. - Common Stock was at 01/15/26 12:25 PM ET

What is the market capitalization of Revelation Biosciences, Inc. - Common Stock?

The market capitalization of Revelation Biosciences, Inc. - Common Stock is 5.68M

How many shares of Revelation Biosciences, Inc. - Common Stock are outstanding?

Revelation Biosciences, Inc. - Common Stock has 6M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.